The purpose of this study was to determine the impact of an educational program on the knowledge and practice behavior of health care providers regarding folic acid use for the prevention of neural tube defects.
S ince the U.S. Public Health Service (USPHS) issued its recommendation regarding the use of periconceptional folic acid for the prevention of neural tube defects (NTDs) 10 years ago, 1 numerous programs have been conducted to promote its use among women of childbearing age. Despite these efforts, only one-third of these women, according to polls conducted by the March of Dimes Birth Defects Foundation, report taking folic acid daily and only approximately 20% know that folic acid can prevent birth defects. 2 The most recent poll showed that among the women who did not take folic acid, 90% stated they would likely take it if their health care provider recommended it. However, when asked where they had learned about folic acid, only 25% of the surveyed women identified their physician as the source of information. 2 We report the results of the pre-and post-intervention surveys conducted to evaluate the impact of an educational program on the knowledge and practice behavior of health care providers regarding folic acid use for the prevention of NTDs.
Materials and Methods
Two surveys were sent to all Florida family physicians, nurse midwives, obstetricians/gynecologists, and pediatricians who were members of their respective professional societies. The questions were based on a previous March of Dimes physicians' survey 3 and sought to determine the level of knowledge of the selected health care providers regarding the role of folic acid in the prevention of NTDs 1, 4 and how often they recommended it to women of childbearing age. • Periconceptional use of folic acid can reduce the risk of neural tube defects by 50 to 70%.
• Significantly more health care providers could identify the U.S. Public Health Service-recommended folic acid dose for occurrence prevention after an educational campaign.
• Health care providers who provide obstetric/gynecologic care recommend folic acid more often to their patients than family physicians and pediatricians. During the time between the two surveys, the University of South Florida Birth Defects Center, the March of Dimes, and the Florida Department of Health initiated a variety of activities targeted at health care providers to improve folic acid knowledge and to encourage the routine recommendation of folic acid to women of reproductive age. These activities included articles in state professional publications, presentations at continuing medical education courses, direct mailings, and educational booths at professional meetings.
Results
We received 1,489 responses to the baseline survey, for a response rate of just over 29%. The second survey response rate increased to 32%, with 1,765 completed surveys returned. Response rates among provider groups varied greatly. Nurse midwives had the highest response rate for both surveys (68 and 47%), and family practice physicians had the lowest (24 and 29%). The response rate for pediatricians declined from 35% in the baseline survey to 31% in the second survey, whereas the obstetricians/gynecologists' response rate improved from 26 to 38%.
There was little variation in the respondent demographics between the two surveys. For both, the majority of respondents graduated before 1992 and had been in practice for 15 or more years. Of those responding to the second survey, 11% reported participating in the previous survey, 45% said they had not, and 43% could not remember. Overall, statistically significant increases in knowledge were noted in the second survey (Table 1) . Knowledge of the USPHS-recommended dose of folic acid (400 g) among respondents increased 12 percentage points to 70% (P Ͻ 0.0001) and knowledge of the recurrence prevention dose (4 mg) increased 10 percentage points to 36% (P Ͻ 0.0001). In the baseline survey, 80% of respondents knew that folic acid should be taken at least 1 month before conception, whereas 85% did in the second survey (P Ͻ 0.0001).
Knowledge of the dose of folic acid recommended by the USPHS for occurrence prevention showed statistically significant differences between the two surveys among the physician groups. These reached more than 15 percentage point increases for both obstetricians/gynecologists (from 74 to 89%; P Ͻ 0.0001) and pediatricians (from 48 to 65%; P Ͻ 0.0001) and seven percentage points for family physicians (from 58 to 65%; P ϭ 0.009). Similar results were found for knowledge of the recommended folic acid dose to prevent NTD recurrence. The largest change in knowledge was seen for obstetricians/gynecologists, with a 20-percentage point increase (from 53 to 73%; P Ͻ 0.0001). Changes were also found among pediatricians (from 20 to 27%; P ϭ 0.011) and family physicians (from 21 to 28%; P ϭ 0.006). In the baseline survey, the vast majority of each health care provider group knew that for the USPHS-recommended 400-g dose to be effective, consumption must be initiated at least 1 month before conception (periconceptional use). This trend remained in the second survey, with significant changes found for family physicians (from 77 to 82%; P ϭ 0.022), obstetricians/ gynecologists (from 87 to 94%; P ϭ 0.040), and pediatricians (from 77 to 83%; P ϭ 0.026). Among nurse midwives, 82% recognized the occurrence prevention dose of folic acid in the baseline survey, and the increase of six percentage points observed in the second survey was not statistically significant (P ϭ 0.137). This group's knowledge of the recurrence prevention dose of folic acid went from 45 to 48% (P ϭ 0.595), and virtually no change was found in their knowledge that folic acid use must be initiated at least 1 month before conception (from 94 to 96%; P ϭ 0.560).
Regarding the practice of recommending folic acid to women of childbearing age, nurse midwives and obstetricians/gynecologists improved from slightly more than 60% in the baseline survey to more than 80% in the second survey. Family physicians went from 41 to 51% (P ϭ 0.001), but there was a nonsignificant increase among pediatricians (from 39 to 42%; P ϭ 0.348).
Additional analysis showed that the year when the health care provider obtained his or her degree had an impact on folic acid knowledge and practice behavior. Those who graduated in 1992 or later compared with those who graduated before 1992 were more likely to know the recommended dose for occurrence (74 and 61%, respectively; P Ͻ 0.0001). A similar trend was found between the two groups regarding the knowledge of when to take folic acid, with 91% of the post-1992 graduates knowing when to take folic acid compared with 80% of pre-1992 graduates (P Ͻ 0.0001). Little difference was observed between the pre-1992 graduation group (31%) and those who graduated later (34%; P ϭ 0.157) in identifying the recurrence prevention dose of folic acid. In contrast, 53% of health care providers who were pre-1992 graduates compared with 48% of post-1992 graduates tended to recommend folic acid most of the time or always (P ϭ 0.050).
Discussion
Our findings demonstrate a positive impact of the educational campaign on folic acid-related knowledge and practice behavior of health care providers. Even among obstetricians, however, whose general knowledge about folic acid was high, 1 in 10 still did not identify the dose recommended to prevent occurrences of NTDs and almost one in four still did not recognize the dose recommended to prevent recurrences. Although nurse midwives were most likely to identify the correct responses, their impact on the incidence of NTDs may be limited by the fact that obstetricians manage the majority of pregnancies. The lower level of knowledge regarding folic acid use among family physicians and pediatricians is of concern. Family physicians provide preventive health care to large numbers of women of childbearing age and, therefore, play an important role in the prevention of NTDs. Pediatricians, during routine office visits, are in a unique position to contribute to the prevention of birth defects through education of mothers of younger children and when caring for adolescents.
Of greatest concern is that those health care providers who have the appropriate knowledge do not communicate this information to their patients. This discrepancy, which was also evident in the previously cited studies, 3, 5, 6 suggests that efforts to modify provider practice behavior are needed, especially as women would be more likely to take folic acid if advised by a physician or other health professional. 2 There are limitations to our survey data. First, the response rate was lower than those found in a review of the literature, which showed an average physician response rate to surveys of 54 Ϯ 17% and 61 Ϯ 23% for nurses. 7 The low response rate may indicate poor interest or lack of familiarity with this type of problem. For both surveys, however, more than 3,200 health care providers returned their responses. Second, we were not able to analyze the demographics of the nonrespondents. Even with these limitations, the data do offer insight into the knowledge and practice behavior of some Florida health care providers about folic acid and its role in the prevention of NTDs.
Conclusion
These surveys show that the folic acid educational program resulted in a positive change in the knowledge of health care providers regarding its use in the prevention of NTDs. However, 35% of family physicians and pediatricians still could not identify the correct folic acid dose to prevent occurrences of NTD. In addition, approximately 50% of these two groups fail to recommend folic acid on a regular basis to women of childbearing age. It seems that knowledge of the role of folic acid to prevent NTD is still lacking. It is critical that educational efforts targeted at health care providers be continued with increased emphasis on incorporating the folic acid message into their routine patient counseling.
